Humana 2004 Annual Report Download - page 119

Download and view the complete annual report

Please find page 119 of the 2004 Humana annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 124

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124

Humana Inc.
SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS
For the Years Ended December 31, 2004, 2003, and 2002
(in thousands)
Additions
Balance at
Beginning
of Period
Acquired
Balances
Charged
(Credited) to
Costs and
Expenses
Charged to
Other
Accounts (1)
Deductions
or
Write-offs
Balance at
End of
Period
Allowance for loss on receivables:
2004 ......................... $40,400 $355 $ 6,433 $(1,338) $(11,344) $34,506
2003 ......................... 30,178 7,416 6,584 (3,778) 40,400
2002 ......................... 38,539 5,990 (4,412) (9,939) 30,178
Deferred tax asset valuation allowance:
2004 ......................... 26,978 (6,855) 20,123
2003 ......................... 36,470 (9,492) 26,978
2002 ......................... 11,942 24,528 36,470
(1) Represents changes in retroactive membership adjustments to premium revenues as more fully described in
Note 2 to the consolidated financial statements.
109